Scarica l'app Stockscreener
3.6199
3.58%
0.1299
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana CEO Steve Harr to give business update in May 12 webcast - Stock Titan
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - The Globe and Mail
MSN Money - MSN
SANA stock rallies 24% after hours — how much is Mayo Clinic investing in the company? - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3%Time to Sell? - MarketBeat
Sana Biotechnology abstract accepted for presentation at ASGCT By Investing.com - Investing.com India
Sana Biotechnology to present preclinical CAR-T data at May meeting - Investing.com
Sana Biotechnology abstract accepted for presentation at ASGCT - Investing.com
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - ChartMill
Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN
Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes - Yahoo Finance
Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat
Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed - Quiver Quantitative
Sana Biotechnology, Inc. Files Form 8-K Current Report with SEC – Key Company Information and Details - Minichart
Sana Biotechnology | DEFA14A: Others - Moomoo
Sana Biotechnology reclassifies board member to balance director classes By Investing.com - Investing.com Australia
Sana Biotechnology Rebalances Board Classes With Director Shift - TipRanks
Sana Biotechnology reclassifies board member to balance director classes - Investing.com UK
Sana Biotechnology | DEF 14A: Definitive information statements - Moomoo
Sana Biotechnology (SANA) details 2026 virtual meeting, board elections and EY ratification - Stock Titan
Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy CollaborationWhat's Changed - Sahm
Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment - Yahoo Finance
Sana Biotechnology (SANA) Trading Range | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử Tỉnh Sơn La
Sana Biotechnology (SANA) Stock Stock Dividend (Grinds Lower) 2026-04-22Popular Trader Picks - Cổng thông tin điện tử tỉnh Lào Cai
Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - Sahm
Sana Biotechnology Partners with Mayo Clinic for Diabetes Research - HarianBasis.co
Sana Biotechnology | 8-K: Current report - Moomoo
Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7%What's Next? - MarketBeat
10 Stocks Under $5 with Huge Upside Potential - Insider Monkey
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
SANA Should I Buy - Intellectia AI
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race - Benzinga
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):